• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Transcatheter Cardiovascular Therapeutics symposium (TCT)

TCT 2016: The best of the rest

November 3, 2016 By Brad Perriello

The annual Transcatheter Cardiovascular Therapeutics conference went down in Washington, D.C., this week, with late-breaking study results beginning Oct. 29. After stents took center stage Day 1, with a raft of studies covering the latest on the bioresorbable front, transcatheter valve replacements were the focus on Day 2. Day 3 saw a wider variety of topics, […]

Filed Under: Cardiovascular, Catheters, Clinical Trials Tagged With: TCT 2016, Transcatheter Cardiovascular Therapeutics symposium (TCT)

TCT 2016: Structural heart, drug-coated balloons take their turn on Day 3

November 2, 2016 By Brad Perriello

The annual Transcatheter Cardiovascular Therapeutics conference is under way in Washington, D.C., with late-breaking study results beginning Oct. 29. We’ll update this post throughout the day as new results come in, so be sure to check back for the latest news out of TCT 2016. After stents took center stage Day 1, with a raft of […]

Pages: Page 1 Page 2 Page 3 Page 4

Filed Under: Cardiac Implants, Cardiovascular, Clinical Trials, Drug-Device Combinations Tagged With: Drug-Eluting Balloons, TCT 2016, Transcatheter Cardiovascular Therapeutics symposium (TCT)

TCT 2016: TAVR to the fore on Day 2

November 1, 2016 By Brad Perriello

The annual Transcatheter Cardiovascular Therapeutics conference is under way in Washington, D.C., with late-breaking study results beginning Oct. 29. We’ll update this post throughout the day as new results come in, so be sure to check back for the latest news out of TCT 2016. After stents took center stage Day 1, with a raft of […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9

Filed Under: Cardiovascular, Catheters Tagged With: Claret Medical Inc., TCT 2016, Transcatheter Cardiovascular Therapeutics symposium (TCT)

TCT 2016: Stents, stents, stents on Day 1

October 31, 2016 By Brad Perriello

The annual Transcatheter Cardiovascular Therapeutics conference is under way in Washington, D.C., with late-breaking study results beginning yesterday. We’ll update this post throughout the day as new results come in, so be sure to check back for the latest news out of TCT 2016. Stents took center stage Day 1, with a raft of studies covering […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9

Filed Under: Cardiovascular, Stents Tagged With: TCT 2016, Transcatheter Cardiovascular Therapeutics symposium (TCT)

Report: Boston Scientific pauses Lotus Edge heart valve in Europe

October 31, 2016 By Brad Perriello

Boston Scientific (NYSE:BSX) is reportedly pausing implantations of its next-generation Lotus Edge replacement heart valve in Europe to investigate a locking mechanism issue. Marlborough, Mass.-based Boston Scientific has implanted about 200 of the Lotus Edge transcatheter aortic valve replacements in Europe, according to Barclays analyst Matthew Taylor, encountering about a 4% rate of “some issues with […]

Filed Under: Cardiovascular, Clinical Trials, Replacement Heart Valves Tagged With: Boston Scientific, TCT 2016, Transcatheter Cardiovascular Therapeutics symposium (TCT)

Abiomed touts survival rates for its Impella right-side heart pump | TCT 2014 Roundup

September 17, 2014 By Arezu Sarvestani Leave a Comment

TCT 2014 Roundup

Abiomed (NSDQ:ABMD) got some Wall Street love today after releasing positive outcomes from a clinical trial of its minimally invasive Impella Right Percutaneous heart pump.

Researchers reported an overall 73% 30-day survival rate in the small study of patients with right ventricular heart failure, according to data Abiomed released during the Transcatheter Cardiovascular Therapeutics conference in Washington D.C.

Filed Under: News Well, Replacement Heart Valves Tagged With: Abiomed, Claret Medical Inc., Conference coverage, InspireMD, Minimally Invasive Surgery, stjudemedical, TCT 2014, Transcatheter Cardiovascular Therapeutics symposium (TCT)

TCT 2014: Medtronic’s IN.PACT Admiral beats PTA in outcomes, costs

September 16, 2014 By Arezu Sarvestani Leave a Comment

TCT 2014: Medtronic's Admiral drug-coated balloon beats PTA in outcomes, cost

Filed Under: News Well Tagged With: Clinical Trials, Conference coverage, Minnesota, Peripheral, TCT 2014, Transcatheter Cardiovascular Therapeutics symposium (TCT)

TCT 2013: Is the Lutonix drug-coated balloon overblown? | MassDevice.com On Call

November 4, 2013 By Brad Perriello Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL — Six-month data from the Levant-2 trial of C.R. Bard‘s (NYSE:BCR) Lutonix drug-coated balloon for treating femoropopliteal artery disease came as a surprise for those hoping the device will be a breakthrough treatment for peripheral artery disease.

Filed Under: News Well Tagged With: C.R. Bard, Lutonix Inc., Peripheral, TCT 2013, Transcatheter Cardiovascular Therapeutics symposium (TCT)

Deflating the hype: Are we setting renal denervation up for disappointment?

November 1, 2013 By Arezu Sarvestani Leave a Comment

Deflating the hype: Are we setting renal denervation up for disappointment?

Renal denervation is still in its youth, but the limited clinical trials and lack of substantial confirmation hasn’t curbed much of the hype for the technology as a means of treating patients with resistant hypertension.

Filed Under: News Well Tagged With: Boston Scientific, Clinical Trials, Conference coverage, Hypertension, MassDevice Q&A, Renal, stjudemedical, Transcatheter Cardiovascular Therapeutics symposium (TCT)

From Moneyball to medtech: Author Michael Lewis on the mindset of a disruptor

October 30, 2013 By Arezu Sarvestani Leave a Comment

From Moneyball to medtech: Author Michael Lewis on the mindset of a disruptor

There’s no formula for disruptive innovation, but there are certain traits that seem to crop up time and again in the individuals who drive it.

Filed Under: News Well Tagged With: Boston Scientific, Conference coverage, Innovation, Transcatheter Cardiovascular Therapeutics symposium (TCT)

Medtronic’s CoreValve skips FDA panel review on path to U.S. market

October 29, 2013 By Arezu Sarvestani Leave a Comment

TCT 2013: Medtronic's CoreValve to skip FDA expert panel review

Filed Under: News Well, Pre-Market Approval (PMA), Regulatory/Compliance, Replacement Heart Valves Tagged With: Clinical Trials, Minnesota, Transcatheter Cardiovascular Therapeutics symposium (TCT)

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS